DELTA Introduction: A New Brain Mapping Tool
Synaptic plasticity responds to experience by altering neuronal connections, which is thought to underlie learning and memory. However, the loci at which synaptic plasticity associated with learning occurs and the extent to which plasticity is localized or widely distributed remain unknown. Recently, Nelson Spruston of the Howard Hughes Medical Institute published a related paper in Nature Neuroscience proposing a method for whole-brain measurement of synaptic protein turnover, DELTA, which reveals localized plasticity changes during learning.
DELTA: A New Brain Mapping Tool
The foundational architecture of DELTA technology integrates two critical elements: advanced Janelia Fluor (JF) fluorescent dyes and bespoke HaloTag knock-in mouse models. This combination provides a powerful platform enabling the precise determination of protein lifespan in vivo through rigorously controlled pulse-tracking experimental paradigms. Methodologically, the process initiates with the systemic administration ('pulse') of a specific JF dye variant to the subject organism, facilitating covalent labeling of the target HaloTag-fusion protein cohort. Following a defined temporal interval, a second, spectrally distinct JF dye ('tracking') is introduced via perfusion. Subsequent quantitative analysis, specifically comparing the relative proportions of protein molecules labeled by the pulse versus the tracking dyes in conjunction with the known elapsed duration, permits the accurate calculation of the average protein population lifespan.
Fig.1 Measurement of protein turnover in vivo.1
The DELTA technology is able to measure the lifespan of proteins at high resolution on a brain-wide scale and can detect differences between different brain regions.
Fig.2 MeCP2–HT neuronal nuclei lifetime.1
The capacity to scrutinize protein turnover dynamics within living systems via pulse-tracking experiments, afforded by the DELTA methodology, promises profound new perspectives on the molecular architecture underpinning synaptic plasticity and learning phenomena. Significantly, DELTA permits concurrent deployment alongside indicators or modulators of neural activity. This integrated approach facilitates direct interrogation of the intricate relationship between neuronal activity states and the kinetics of protein turnover. The method's utility spans both healthy murine models and established animal paradigms of cerebral pathology. Consequently, DELTA offers a powerful means to delineate organ-wide proteomic alterations—correlating with adaptive and maladaptive processes—achieving this identification with exceptional clarity, efficiency, and granular detail.
Applications
DELTA technology brings new opportunities for neuroscience research.
- It can be utilized to study the turnover of more proteins in different physiological and pathological states and deepen the understanding of basic brain functions and disease mechanisms.
- Combining DELTA with other advanced technologies to explore the relationship between neural activity and protein turnover in multiple dimensions will provide a theoretical basis for tackling neurological diseases and developing new therapies.
Contact Us to Tailor the Best-Fit Solutions for Your Neuroscience Research
As a specialized Contract Research Organization operating within the neurobiology sector, we are fundamentally committed to furnishing clients with exceptionally efficient and professional services. Although Creative Biolabs does not offer the DELTA tool, our explicit aim is to catalyze significant breakthroughs in both foundational neuroscience and the intricate study of neurodegenerative disorders. Engaging our organization ensures partnership with a profoundly science-driven team. This dedicated group not only commands deep domain expertise but also possesses the critical operational agility requisite for addressing complex, non-standard experimental challenges and requirements.
Resources
Reference
- Mohar, Boaz, et al. "DELTA: a method for brain-wide measurement of synaptic protein turnover reveals localized plasticity during learning." Nature Neuroscience (2025): 1-10. Distributed under Open Access license CC BY 4.0, without modification.

- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)